This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Walmart & Medtronic Report Earnings
by Zacks Equity Research
Walmart & Medtronic Report Earnings
Medtronic (MDT) Beats on Q3 Earnings, Gross Margin Down
by Zacks Equity Research
Medtronic (MDT) demonstrates improved performances at CER based on growth in most of the business segments and all geographies.
Data Slows as Q4 Wanes; Walmart (WMT) Tops Estimates
by Mark Vickery
The world's largest big-box retailer outperformed expectations on both its top and bottom lines for fiscal Q4: $1.41 per share surpassed the $1.33 in the Zacks consensus.
Medtronic Posts Prelim PRODIGY Outcome on Opioid Overdose
by Zacks Equity Research
The favorable PRODIGY study result by Medtronic (MDT) is undoubtedly a timely, strategic finding.
Medtronic (MDT) Q3 Earnings Tops, Revenues Miss Estimates
by Zacks Equity Research
Medtronic (MDT) gains on strength in the Minimally Invasive Therapies and Restorative Therapies Groups along with solid performance across emerging markets in Q3.
Here's What Will Give Shape to Medtronic's (MDT) Q3 Earnings
by Zacks Equity Research
Medtronic (MDT) is expected to maintain a decent market share in the core pacing backed by the continued uptake of Micra Transcatheter Pacing System in Q3.
Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed at $90.67 in the latest trading session, marking a +0.47% move from the prior day.
Medtronic (MDT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medtronic (MDT) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed the most recent trading day at $88.90, moving +0.05% from the previous trading session.
Medtronic (MDT) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Medtronic (MDT) closed at $87.23, marking a +0.08% move from the previous day.
Medtronic (MDT) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Medtronic (MDT) closed at $89.26, marking a -0.44% move from the previous day.
Medtronic's Growth Across All Lines Aid, Rising Costs Ail
by Zacks Equity Research
Of late, Medtronic (MDT) succeeds in delivering solid top-line growth at CER, backed by balanced growth across major business operation.
The Zacks Analyst Blog Highlights: Amazon, Johnson & Johnson, Home Depot, Medtronic and Paychex
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amazon, Johnson & Johnson, Home Depot, Medtronic and Paychex
Top Stock Reports for Amazon, Johnson & Johnson & Home Depot
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Amazon (AMZN), Johnson & Johnson (JNJ) and Home Depot (HD).
Medtronic (MDT) Down 1.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Medtronic's Mazor Buyout Creates a New Spine Surgery Major
by Zacks Equity Research
With the acquisition of Mazor Robotics, Medtronic (MDT) expects to offer a fully-integrated procedural solution for surgical planning, execution and confirmation.
Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed at $92 in the latest trading session, marking a +0.16% move from the prior day.
Medtronic (MDT) Stock Moves -0.01%: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed at $95.47 in the latest trading session, marking a -0.01% move from the prior day.
Insulet Gains on Omnipod Reimbursement Update, Rivalry Stiff
by Zacks Equity Research
Insulet Corporation (PODD) continues to expand Omnipod's market access on growing reimbursements. The company operates in a highly competitive environment.
Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Medtronic (MDT) closed the most recent trading day at $98.75, moving +1.25% from the previous trading session.
Medtronic (MDT) Positive on Mazor Purchase, Rising Costs Ail
by Zacks Equity Research
The pending acquisition of Mazor Robotics holds great potential as it is likely to solidify Medtronic's (MDT) position in robotic spine surgery.
The Zacks Analyst Blog Highlights: Amazon, Medtronic, Lowe???s, Target and Hilton
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amazon, Medtronic, Lowe???s, Target and Hilton
RTI Surgical Gains From HealthPartners' Nod for SI Surgery
by Zacks Equity Research
RTI Surgical's (RTIX) minimally invasive SImmetry System sees lucrative market prospects for the stock's growth.
Medtronic's Deal With Nutrino Health to Boost Diabetes Arm
by Zacks Equity Research
Bringing Nutrino under Medtronic's (MDT) Diabetes Group will help the acquirer speed up its growth in the same business.
Play Medtronic's Q2 Earnings Beat With These 2 Funds
by Zacks Equity Research
Following Medtronic's encouraging earnings results, investing in health care mutual funds with a significant holding in the company will be prudent